Recommended Conferences

Neuroscience Psychiatry

Dubai, UAE

2nd International Conference on Clinical Psychiatry

Miami, USA

Psychology and Mental Health

Chicago, USA
Related Subjects
 

Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review

Author(s): Moore THN, Zammit S, Lingford-Hughes A, Barnes TRE, Jones PB

Abstract

Background

Whether cannabis can cause psychotic or affective symptoms that persist beyond transient intoxication is unclear. We systematically reviewed the evidence pertaining to cannabis use and occurrence of psychotic or affective mental health outcomes.

Methods

We searched Medline, Embase, CINAHL, PsycINFO, ISI Web of Knowledge, ISI Proceedings, ZETOC, BIOSIS, LILACS, and MEDCARIB from their inception to September, 2006, searched reference lists of studies selected for inclusion, and contacted experts. Studies were included if longitudinal and population based. 35 studies from 4804 references were included. Data extraction and quality assessment were done independently and in duplicate.

Findings

There was an increased risk of any psychotic outcome in individuals who had ever used cannabis (pooled adjusted odds ratio=1·41, 95% CI 1·20–1·65). Findings were consistent with a dose-response effect, with greater risk in people who used cannabis most frequently (2·09, 1·54–2·84). Results of analyses restricted to studies of more clinically relevant psychotic disorders were similar. Depression, suicidal thoughts, and anxiety outcomes were examined separately. Findings for these outcomes were less consistent, and fewer attempts were made to address non-causal explanations, than for psychosis. A substantial confounding effect was present for both psychotic and affective outcomes.

Interpretation

The evidence is consistent with the view that cannabis increases risk of psychotic outcomes independently of confounding and transient intoxication effects, although evidence for affective outcomes is less strong. The uncertainty about whether cannabis causes psychosis is unlikely to be resolved by further longitudinal studies such as those reviewed here. However, we conclude that there is now sufficient evidence to warn young people that using cannabis could increase their risk of developing a psychotic illness later in life.

Similar Articles

A role for cannabinoid CB1 receptors in mood and anxiety disorders

Author(s): Witkin JM, Tzavara ET, Nomikos GG

Adverse health effects of non-medical cannabis use

Author(s): Hall W, Degenhardt L

Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders

Author(s): Kumra S, Robinson P, Tambyraja R, Jensen D, Schimunek C, et al.

Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users

Author(s): Di Forti M, Sallis H, Allegri F, Trotta A, Ferraro L, et al.

Prevalence and intensity of basic symptoms among cannabis users: An observational study

Author(s): Martinotti G, Di Iorio G, Tedeschi D, De Berardis D, Niolu C, et al.

Rates of psychiatric comorbidity among U

Author(s): Agosti V, Nunes E, Levin F

Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts

Author(s): Manrique-Garcia E, Zammit S, Dalman C, Hemmingsson T, Allebeck P

Escalation of drug use in early-onset cannabis users vs

Author(s): Lynskey MT, Heath AC, Bucholz KK, Slutske WS, Madden PA, et al.

A co twin-control analysis of drug use and abuse/dependence risk associated with early-onset cannabis use

Author(s): Grant JD, Lynskey MT, Scherrer JF, Agrawal A, Heath AC, et al.

Genetic predisposition to schizophrenia associated with increased use of cannabis

Author(s): Power RA, Verweij KJH, Zuhair M, Montgomery GW, Henders AK, et al.

The association between cannabis use and depression: A systematic review and meta-analysis of longitudinal studies

Author(s): Lev-Ran S, Roerecke M, Le Foll B, George TP, McKenzie K, et al.

Major depression: The relative contribution of gender, MDMA and cannabis use

Author(s): Durdle H, Lundahl LH, Johanson CE, Tancer M

Relief-oriented use of marijuana by teens

Author(s): Bottorff JL1, Johnson JL, Moffat BM, Mulvogue T

Motives for drug use among light and heavy users

Author(s): Nail RL, Gunderson EK, Kolb D

Risk factors predicting changes in marijuana involvement in teenagers

Author(s): Van den Bree, Marianne BM, Wallace BP

Affect dysregulation in cannabis abusers: A study in adolescents and young adults

Author(s): Dorard G, Berthoz S, Phan O, Corcos M, Bungener C

Adolescent depression and risk factors

Author(s): Field T, Diego M, Sanders C

Cannabis, motivation and life satisfaction in an internet sample

Author(s): Barnwell SS, Earleywine M, Wilcox R

Sequencing of substance use and affective morbidity in 166 first episode bipolar I disorder patients

Author(s): Baethge C, Hennen J, Khalsa HM, Salvatore P, Tohen M, et al.

Adverse health effects of marijuana use

Author(s): Volkow ND, Baler RD, Compton WM, Weiss SR